|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000009404 |
|
Date of registration:
|
30/11/2012 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Neuroimaging study of dopaminergic neurotransmission in depresive state
|
|
Scientific title:
|
Neuroimaging study of dopaminergic neurotransmission in depresive state - Neuroimaging study of dopaminergic neurotransmission in depresive state |
|
Date of first enrolment:
|
2012/12/01 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010286 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel Non-randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Tetsuya Suhara MD, PhD |
|
Address:
|
Anagawa 4-9-1, Inage-ku, Chiba, 263-8555, Japan
Japan |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Institute of Radiological Sciences Molecular Imaging Center |
|
|
Name:
|
|
|
Address:
|
Japan |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Institute of Radiological Sciences Molecular Imaging Center |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Exclusion criteria for patients 1) Serious suicidal ideation or behavior 2) Co-morbid other psychiatric disorders including drug dependence 3) Subjects taking antidepressants or antipsychotic agents within 28 days before the examination 4) Existence of brain organic disease, including current or past history of cerebrovascular disease, Parkinson's disease, and other related disorders 5) Existence of serious medical illnesses 6) Subjects who are judged by researchers as not suitable for participation in the study
Age minimum:
20years-old
Age maximum:
60years-old
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
mood disorder and adjustment disorder
|
|
Intervention(s)
|
PET, MRI
PET, MRI
PET, MRI
|
|
Primary Outcome(s)
|
|
The association of Dopamine D1 and D2 receptor binding potentials with clinical features
|
|
Source(s) of Monetary Support
|
|
Ministry of Education
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|